|
Healthy Vision Month
|
Public Education Campaign
|
CDC
|
NEI
|
Each May, the NEI sponsors Healthy Vision Month (HVM) which is a national observance designed to elevate eye health as a priority for Americans. NIH worked closely with CDC for the 2010 observance and worked together to create a Morbidity and Mortality Weekly Report (MMWR) article, develop information for their Vision Initiative website and provided online banners and buttons linking to the HVM site and to the NEI for additional information.
|
|
Hematopoietic Stem Cell Transplantation Interagency Working Group
|
Committee, Work group, Advisory group, or Task Force
|
FDA, HRSA
|
NCI, CC, NHLBI, NIAID, NIDDK
|
This working group reviews matters associated with hematopoietic stem cell transplantation.
|
|
Hemoglobinopathy Uniform Medical Language Ontology Project
|
Resource Development
|
AHRQ, CDC, FDA, HRSA, OS
|
NHLBI, NIAMS, NICHD, NLM
|
The purpose of the project is to create a uniform medical language ontology for hemoglobinopathies. The ontology would be a resource for federal programs and extramural communities (e.g., researchers) to use when developing data systems that incorporate data elements related to hemoglobinopathies.
|
|
Hepatitis B Research Network
|
Research Initiative
|
CDC
|
NIDDK
|
The Hepatitis B Research Network (HBRN) was established in 2008 to advance understanding of disease processes and natural history of chronic hepatitis B, as well as to develop effective approaches to treatment with currently available therapies. The Network brings together clinical centers from throughout the U.S. and Canada. This multi-center Network is enrolling patients in multiple clinical trials in both adults and children with hepatitis B.
|
|
HHS Action Plan for the Prevention, Care and Treatment of Viral Hepatitis Interagency Implementation Group (VHIG)
|
Research Initiative
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, SAMHSA
|
NIDA, NIAID, NIDDK
|
HHS agencies review the Institute of Medicine (IOM) recommendations and develop a comprehensive strategic viral hepatitis action plan that would: address IOM recommendations for viral hepatitis prevention, care, and treatment; set forth actions to improve viral hepatitis prevention and ensure that infected persons are identified and provided care and treatment; and improve coordination of all activities related to viral hepatitis across HHS and promote collaborations with other government agencies and nongovernmental organizations.
|
|
HHS Advisory Committee on Blood & Tissue Safety & Availability (ACBTSA)
|
Committee, Work group, Advisory group, or Task Force
|
CDC, CMS, FDA, HRSA, OS
|
NHLBI
|
This federal advisory committee advises the Secretary of the Department of Health and Human Services and the Assistant Secretary for Health on a number of issues related to blood (and tissue) safety including, public health parameters related to the safety and availability of blood and blood products; broad public health, ethical, and legal issues related to transfusion and transplantation safety; and the effect of various economic factors on blood (and tissue) safety and availability (and infectious disease concerns for organ transplantation). The ACBTSA is a Federal Advisory Committee (i.e., a FACA) seated with industry representatives, physicians/scientists, consumer advocates, and federal ex-officio members from the HHS Agencies, the Department of Defense, and the Department of Veteran''s Affairs.
|
|
HHS Advisory Council for the Elimination of Tuberculosis
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, CDC, FDA, HRSA, IHS, OS, SAMHSA
|
NIAID
|
The Council advises and makes recommendations to the DHHS Secretary, the Assistant Secretary for Health, and the Director, CDC, regarding the elimination of tuberculosis. Specifically, the Council makes recommendations regarding policies, strategies, objectives, and priorities; addresses the development and application of new technologies; and reviews the extent to which progress has been made toward eliminating tuberculosis.
|
|
HHS Behavioral Health Coordinating Committee (BHCC)
|
Committee, Work group, Advisory group, or Task Force
|
ACF, ACL, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA
|
NIMH, NIAAA, NIDA, OD/DPCPSI/OBSSR, OD/OCPL
|
The HHS Behavioral Health Coordinating Committee is a coordinating body within HHS that identifies and facilitates collaborative, action-oriented approaches to addressing the HHS behavioral health agenda. Co-chaired by the Assistant Secretary for Health, Howard Koh, and the Administrator of the Substance Abuse and Mental Health Services Administration, Pam Hyde, the Committee has five subcommittees: Communications; Early Intervention/Institute of Medicine Implementation; Prescription Drug Abuse; Primary Care/Behavioral health Integration; and Underage Drinking and Alcohol Policy. The subcommittees develop projects with clear goals, provide guidance to achieve steady progress and measurable outcomes, and develop key policy messages. The projects and activities build upon existing activities in the proposed areas and are consistent with other important HHS and Federal strategies and initiatives, such as Healthy People, the U.S. Preventive Task Force, and the National Drug Control Strategy.
|
|
HHS Behavioral Health Coordinating Committee (BHCC) Subcommittee on Communications
|
Committee, Work group, Advisory group, or Task Force
|
ACL, OS
|
NIDA, NIMH
|
Committee of communication professionals to collaborate on inter-departmental behavioral health initiatives and promotional efforts.
|
|
HHS Behavioral Health Coordinating Committee (BHCC) Subcommittee on Prescription Drug Abuse
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA
|
NIDA
|
NIDA Serves as Co-Chair with FDA on this inter-agency subcommittee addressing prescription drug abuse.
|